Precision Histology: Artificial Intelligence as a Tool for Pathologists by Reveal Biosciences

Precision Histology: Artificial Intelligence as a Tool for Pathologists The hematoxylin and eosin (H&E) stain has long been an essential tool in the pathologist’s arsenal. Positively-charged hematoxylin and negatively-charged eosin bind to different substances within a tissue sample. This allows pathologists to clearly view different structures within that sample in various shades of blue, violet, […]

Read More

Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities

Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities SOMERSET, N.J. – January 7, 2019— Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has commenced a $200 million capital investment in its Biologics business to expand drug […]

Read More

V I V A Biotech Partnering Reception

V I V A Biotech Partnering Reception Seed and Early-Stage Biotech Investment Experienced | Efficient | Focused Great Track Record: 25+ biotech start-ups in the portfolio Genesis @ 4242 Campus Point, San Diego, Nov. 14, 2018 On Nov. 14th, 2018, Viva Biotech held its inaugural Partnering Reception in San Diego, one of the biotech hubs […]

Read More

Catalent Expands Clinical Packaging Capabilities in Shanghai, China

Catalent Expands Clinical Packaging Capabilities in Shanghai, China SOMERSET, N.J. – November 27, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China has reached […]

Read More

Blog Post by PharmetRx

PharmetRx Capabilities 1) Our company is directly involved in using AI to design clinical trials. We use machine learning and neural networks to predict which patients would be most responsive to a particular therapy, and use this to help clients recruit patients and design stratified clinical trials. Based on our past success, we believe this […]

Read More

BTS Research Appoints Mark Crane as Vice President, Business Development

BTS Research Appoints Mark Crane as Vice President, Business Development November 14, 2018 08:33 PM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–BTS Research, a preclinical services Contract Research Organization, is delighted to announce the addition of Mark T. Crane as Vice President of Business Development. Mark will be taking on the Company’s Marketing, Sales, and Business […]

Read More

Catalent to Open Second Clinical Supply Facility in China

Catalent to Open Second Clinical Supply Facility in China Enables Broader Integrated Solutions for Global and Local Customers SOMERSET, N.J. – November 13, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced its plans to invest $2.5 million in […]

Read More